ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2017

Sep 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2017-09-08

Reporting Person: Cormack Scott Daniel (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-08	Common Stock	F	1491	$3.09	Disposed	14810	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9685	Indirect

Footnotes

F1: Represents shares of common stock that have been withheld by the issuer to satisfy its income tax withholding obligations in connection with the net settlement of restricted stock units reported by the reporting holder on August 3, 2017 in connection with the consummation of the merger on August 1, 2017 between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. and does not represent a sale by the reporting person.